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Cytokeratin expression patterns in benign lesions of Squamous cell-specific reverse-transcriptase-
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polymerase chain reaction for the detection of 
disseminated tumour cells in head and neck cancer 
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The cytokeratin expression patterns of 12 benign lesions of
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j.j.QUAK & G.B.SNOW (Amsterdam)
the larynx and the adjacent mucosa were studied. Intermediate We are focusing on the use of squamous cell carcinoma-
filament proteins are major components of the cytoskeleton. associate antigens and monoclonal antibodies (MAbs) for
The largest subgroup of these proteins are formed by the the detection and treatment of head and neck squamous cell
cytokeratins, which are specific for epithelia. In man, 20 carcinoma. To this end we developed MAb E48. Reactivity
different cytokeratin polypeptides have been identified. The of MAb E48 is restricted to normal squamous epithelia and
individual cytokeratins are related to the different types of their malignant counterparts. Recently, the cDNA encoding
epithelial differentiation. Cytokeratins 1 and 10 expression are 
observed in keratinizing epithelia. The expression of the simple 
cell-related cytokeratins 7, 8, 18 and 19 are seen in the simple 
and complex epithelia. The stratification cytokeratins 4 and 
J3 are expressed in the non-keratinizing stratified epithelia. 
Cytokeratins 5 and 14 are the basal cell markers. Cytokeratins
the MAb E48 defined antigen was cloned and the gene struc­
ture elucidated. On the basis of this molecular information 
intron spanning primers were selected and evaluated in reverse 
transcriptase polymerase chain reactions (RT-PCR) for their 
potential to detect single squamous cancer cells in peripheral 
blood. E48 RT-PCR in combination with Southern blot
6, 16 and 17 are associated with hyperproliferation. In benign hybridization on 30 peripheral blood samples obtained from 
lesions a shift in cytokeratin expression patterns is observed. different healthy donors was negative. We
The expression of cytokeratin 10 in hyperkeratotic lesions is sitivity and specificity of the E48 RT-PCR for tumour detec-
seen. A decrease of the stratification markers cytokeratins 4 
and 13 and an increased expression of the basal cell markers 
cytokeratins 5 and 14 and the hyperproliferative markers cyto-
tion by seeding single cells of the E48-positive HNSCC cell 
line UM-SCC-22A in the peripheral blood of healthy vol­
unteers by micromanipulation. E48 RT-PCR on 7 ml blood
keratins 6 and 16 is observed in the hyperplastic and hyper- samples (containing ±  107 nucleated blood cells) to which 25, 
keratotic lesions. An increase in the expression of cytokeratin 5, or just one tumour cell was added, gave positive results.
19 is seen in epithelial hyperplasia. The simple cytokeratins 7, 
8 and 18 are not expressed. These findings differ from those 
established in squamous cell carcinomas, where the markers 
of simple cell epithelia cytokeratins 7, 8 and 18 show an 
increased expression.
When to four out of eight samples one single tumour cell 
was added, three positive samples could be identified. The 
procedure will be applied for the detection of tumour cells in 
lymph nodes, peripheral blood and bone marrow of patients 
with head and neck cancer.
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